Kidney international reports
July 28, 2026 · via Europe PMC
Comparing Ibuprofen and Loop Diuretics for Protein-Bound Uremic Toxins Clearance During Hemodialysis.
Escudero-Saiz VJ, Cuadrado-Payán E, Rodríguez-García M, +7 more, Maduell F.
AI summary — for doctors, generated from the abstract only
In a small crossover study, infusing ibuprofen directly into the dialysis circuit was the only strategy that significantly improved removal of protein-bound uremic toxins during hemodialysis, outperforming loop diuretics like furosemide and torasemide.
What was studied
A longitudinal, crossover study in 12 chronic hemodialysis patients compared 6 different dialysis strategies (standard online hemodiafiltration, high-flux hemodialysis, oral furosemide or torasemide predialysis, arterial infusion of furosemide, and arterial infusion of ibuprofen) for their ability to displace and remove the protein-bound uremic toxins indoxyl sulfate (IS) and p-cresyl sulfate (pCS), using reduction ratios and repeated-measures ANOVA with Bonferroni correction.
Key findings
- Arterial administration of ibuprofen was the only strategy that significantly enhanced protein-bound uremic toxin removal, achieving mean reduction ratios of 65% for indoxyl sulfate and 60% for p-cresyl sulfate; the exact p-value is truncated/garbled in the available abstract text.
- Furosemide (whether oral or arterial infusion) did not show significant efficacy in improving toxin removal, suggesting a 'ceiling effect' in high-volume hemodiafiltration where only high-affinity albumin-binding competitors like ibuprofen can further displace these toxins.
- The study tested 6 different modalities across 12 patients in a crossover design, allowing within-patient comparison of each strategy.
- Not reported in the abstract (due to truncation): the exact statistical significance level for the ibuprofen finding is not available in the provided text, though the magnitude of improvement (65% and 60% reduction ratios) is given.
Clinical relevance
The findings suggest that pharmacological displacement using ibuprofen infusion could be a promising adjunct strategy to improve removal of protein-bound uremic toxins linked to cardiovascular mortality during hemodialysis, though this requires further study of safety and long-term outcomes before clinical adoption, given ibuprofen's known risks (GI bleeding, cardiovascular effects) in dialysis patients.
Who should care
Limitations
Very small sample size (12 patients); the abstract does not discuss the safety profile or potential risks of arterial ibuprofen infusion in this vulnerable population, which would be an important consideration before clinical use; exact statistical significance value is truncated/garbled in the available abstract text.
In a small crossover study, arterial ibuprofen infusion significantly improved removal of protein-bound uremic toxins during hemodialysis, achieving reduction ratios of 65% and 60% for two key toxins, outperforming loop diuretic strategies.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Introduction
Protein-bound uremic toxins (PBUTs), such as indoxyl sulphate (IS) and p-cresyl sulphate (pCS) are associated with cardiovascular mortality in patients undergoing hemodialysis. Because of their high albumin affinity, conventional dialysis techniques achieve poor clearance. This study aims to evaluate the efficacy of different competitive binding displacement strategies using ibuprofen and loop diuretics during online hemodiafiltration (OL-HDF).
Methods
A longitudinal, cross-over study in 12 patients undergoing chronic hemodialysis was performed. Each patient underwent 6 different dialysis modalities based on postdilutional HDF. The experimental arms included the following: (i) Standard postdilutional HDF (control), (ii) High-flux hemodialysis (HF-HD) (iii) Oral furosemide 1h predialysis, (iv) Oral torasemide 1h predialysis, (v) 1h arterial infusion of furosemide, and (vi) 1h arterial infusion of ibuprofen. Reduction ratios (RR) for IS and pCS were calculated for each session. Statistical analysis was performed using 1-way repeated measures analysis of variance with Bonferroni post hoc correction.
Results
Arterial administration of ibuprofen was the only strategy that significantly enhanced PBUT removal, achieving mean RR of 65% for IS and 60% for pCS (P < 0.05 vs. baseline OL-HDF). In contrast, neither oral nor arterial administration of loop diuretics showed a statistically significant increase in the RR of IS or pCS when compared with OL-HDF. No acute adverse events were reported during the pharmacological interventions.
Conclusion
Prefilter arterial infusion of ibuprofen is the most effective strategy for increasing the intradialytic clearance of IS and pCS during OL-HDF. The lack of efficacy observed with furosemide suggests a ceiling effect in high-volume HDF, where only high-affinity competitors can further displace PBUTs from albumin-binding sites. Pharmacological displacement represents a promising adjunct to convective therapies to optimize protein-bound uremic toxin removal.
DOI
10.1016/j.ekir.2026.106994
PMID
42662542
PMCID
PMC13521145
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed